Protective efficacy of an H5/H7 trivalent inactivated vaccine produced from Re-11, Re-12, and H7-Re2 strains against challenge with different H5 and H7 viruses in chickens

We developed an H5/H7 trivalent inactivated vaccine by using Re-11, Re-12, and H7-Re2 vaccine seed viruses, which were generated by reverse genetics and derived their HA genes from A/duck/Guizhou/S4184/2017(H5 N6)(DK/GZ/S4184/17)(a clade 2.3.4.4 d virus), A/chicken/Liaoning/SD007/2017(H5 N1)(CK/LN/SD007/17)(a clade 2.3.2.1 d virus), and A/chicken/Guangxi/SD098/2017(H7 N9)(CK/GX/SD098/17), respectively. The protective efficacy of this novel vaccine and that of the recently used H5/H7 bivalent inactivated vaccine against different H5 and H7 N9 viruses was evaluated in chickens. We found that the H5/H7 bivalent vaccine provided solid protection against the H7 N9 virus CK/GX/SD098/17, but only 50–60% protection against different H5 viruses. In contrast, the novel H5/H7 trivalent vaccine provided complete protection against the H5 and H7 viruses tested. Our study underscores the importance of timely updating of vaccines for avian influenza control.     

河南省肉鸡4株禽传染性支气管炎病毒的分离鉴定及S1基因序列分析

通过病料接种SPF鸡胚和鸡胚尿囊液的RT-PCR鉴定,于2017至2018年从河南省不同发病鸡场分离到4株鸡传染性支气管炎病毒(IBV),分别命名为HB/L1/201711、ZMD/L2/201704、SQ/L3/201803、LY/L4/201710,并对4株毒株S1基因进行克隆和序列分析。结果:HB/L1/201711、SQ/L3/201803 S1基因全长1 620 nt,编码540 aa,其裂解位点分别为HRRRR,分属于基因型V、Ⅰ分支;ZMD/L2/201704、LY/L4/201710株S1基因全长1 617 nt,编码539 aa,其裂解位点为RRSRR,属于基因型Ⅱ分支。ZMD/L2/201704与LY/L4/201710分离株核苷酸序列及其推导的氨基酸序列同源性较高,分别为97.6%、95.4%,与另外2株分离株之间核苷酸序列同源性为76.5%、76.8%。4株分离株与国内外参考毒株及疫苗株的氨基酸序列同源性在58.5%~98%之间,具有较大的差异性。其中:ZMD/L2/201704、LY/L4/201710与491型传支疫苗氨基酸同源性较高,可达95.4%、95.9%;SQ/L3/201803与CHI分支参考毒株氨基酸同源性在94.6%~98.9%之间;HB/L1/201711与TWⅠ型毒株2575/98、3468/07有较高同源性,分别为94.8%和93.5%。本研究表明河南省肉鸡鸡群鸡传染性支气管炎病毒基因型相对复杂,推测存在重组与突变。     

H9N2禽流感病毒全基因组密码子使用偏好性及影响因素分析

【目的】探究H9N2禽流感病毒(AIV)全基因组的密码子使用偏好性及影响因素。【方法】选取2010—2018年国内H9N2 AIV流行毒株的全基因组为研究对象,分析其碱基组成特性、最优密码子、密码子使用偏好性的影响因素以及病毒对宿主密码子使用模式的适应性。【结果】H9N2 AIV的全基因组中AU含量高于GC。大部分最优密码子以A或U结尾,有效密码子数(ENC)平均值为52.86,提示存在密码子使用偏好性但偏好性较低。密码子使用偏好性主要受到突变压力和自然选择的共同作用,其中自然选择(所占比例为61.79%～76.15%)作用大于突变压力(所占比例为23.85%～38.21%)。H9N2 AIV对人Homo sapiens的密码子适应指数平均值为0.739～0.741,提示H9N2AIV禽流感病毒可能已适应人类的密码子使用模式。【结论】本研究为H9N2 AIV的基因进化分析、已有疫苗的密码子优化和新型疫苗(密码子去优化疫苗)研制提供了理论依据。     

Development of a reverse-transcription loop-mediated isothermal amplification assay to detect avian influenza viruses in clinical specimens

In recent years, the avian influenza has brought not only serious economic loss to the poultry industry in China but also a serious threat to human health because of the avian influenza virus(AIV) gene recombination and reassortment. Until now, traditional RT-PCR, fluorescence RT-PCR and virus isolation identification have been developed and utilized to detect AIV, but these methods require high-level instruments and experimental conditions, not suitable for the rapid detection in field and farms. In order to develop a rapid, sensitive and practical method to detect and identify AIV subtypes, 4 specific primers to the conserved region of AIV M gene were designed and a loop-mediated isothermal amplification(RT-LAMP) method was established. Using this method, the M gene of H1–H16 subtypes of AIV were amplified in 30 min with a water bath and all 16 H subtypes of AIV were able to be visually identified in presence of fluorescein, without cross reaction with other susceptible avian viruses. In addition, the detection limit of the common H1, H5, H7, and H9 AIV subtypes with the RT-LAMP method was 0.1 PFU(plaque-forming unit), which was 10 times more sensitive than that using the routine RT-PCR. Further comparative tests found that the positivity rate of RT-LAMP on detecting clinical samples was 4.18%(14/335) comparing with 3.58%(12/335) from real-time RT-PCR. All these results suggested that the RT-LAMP method can specifically detect and identify AIV with high sensitivity and can be considered as a fast, convenient and practical method for the clinic test and epidemiological investigation of AIV.     

纳米疫苗在禽流感防控中的研究进展

禽流感病毒(Avian influenza virus,AIV)因其具有变异性强、亚型种类多、感染宿主多样性等特点,对畜牧业发展及公共卫生安全具有巨大的影响。目前,传统灭活疫苗在预防禽流感中虽起着重要作用,但仍存在免疫失败、多次接种及易出现不良反应等弊端,因此,研制新型疫苗来弥补传统疫苗的不足非常有必要。纳米颗粒疫苗具有包裹性好、结构稳定、靶向性高和免疫原性强等优点,可作为新型流感病毒疫苗的候选。笔者首先介绍了禽流感难以防控的原因及纳米疫苗的特点,然后对病毒样颗粒疫苗、自组装蛋白疫苗、聚合物纳米颗粒疫苗、无机纳米颗粒疫苗及纳米颗粒的毒性机制方面进行综述,概述了近年来AIV纳米颗粒疫苗的研究进展,并简述了采用不同抗原、不同纳米材料及不同给药方式对免疫效果的影响,结合目前纳米疫苗的研究,预测了未来纳米颗粒疫苗可作为AIV防控的一种新途径,对禽流感纳米疫苗在兽医临床的应用前景进行了分析和展望。     

一株野鸟源H9N2亚型禽流感病毒的全基因组序列分析及致病性研究

为进一步了解2014年分离自我国南方野鸟粪便中的一株H9N2亚型禽流感病毒(AIV)Wide Bird/Hu N/SC1400/2014(H9N2)(WB/400/14)的生物学特性,本研究对其进行全基因组序列测定、进化分析及SPF鸡、SPF鸭和BALB/c小鼠的感染性试验。序列分析显示:该分离株的HA裂解位点基序为333PAASDR↓GL340,其中不存在多个连续的碱性氨基酸,符合低致病性禽流感病毒(LPAIV)氨基酸序列特征。该分离株不同基因片段来源较复杂,分别与H9、H6、H4、H1、H11、H10、H3等多种亚型的LPAIV同源性较高,呈现明显的多样性。感染性试验显示,WB/400/14不能够在SPF鸡和小鼠体内有效复制,但病毒感染SPF鸭后能够在部分脏器中检测到病毒的存在,并且感染鸭能通够过咽喉和泄殖腔同时向外排毒,而同居感染鸭仅通过泄殖腔向外排毒,表明分离株在SPF鸭群中具有良好的水平传播能力。本研究为AIV的监测和防控提供实验依据。     

Isolation and Identification of one Strain of H9 Subtype Avian Influenza Virus and Study on its Biological Characteristics

In 2013,one case of suspected H9 subtype avian influenza occurred in a chicken farm of Jilin povince.Clinical samples were collected from the diseased farm,inoculated into the allantoic cavity of 9-day-old SPF chicken embryo,and then one strain of virus was isolated.The results of HA test,HI test and molecular biology test all showed that the isolate belonged to H9 subtype avian influenza virus (AIV).The HA cleavage site of the isolate was RSSR↓GLF,which was consisted with the molecular characteristic of low pathogenic AIV.The HA peptide chain had 9 potential glycosylation sites which were same as other isolates of recent years.The isolate had 8 receptor binding sites,including 234 receptor binding site by glutamine (Q) mutating into threonine (T).The phylogenetic tree revealed the isolate belonged to Eurasian lineages and it had far genetic relationship with the earliest domestic isolate (A/Chicken/Beijing/1/94(H9N2)),but had close genetic relationship with the representative strain (A/Chicken/Guangxi/55/2005(H9N2)) of major epidemic branch since 2007.We prepared an inactivated oil-emulsion vaccine of the isolate,and then vaccinated SPF chicken.21 days after vaccination,the HI titer of chicken serum antibody reached up to 10log2.The result suggested the isolate had good immunogenicity.     

Cloning and Sequence Analysis of N and M Genes of Avian Infectious Bronchitis Virus Guangxi Strain

To investigate genetic variation of avian infectious bronchitis virus (IBV) in Guangxi province,one strain of IBV was isolated from chicken.Two pairs of primers for amplifying the N and M genes of IBV were designed according to the sequences in GenBank.The N and M genes of the strain were amplified by RT-PCR,and they were proved to be the N and M genes of IBV by cloning,sequencing and compared with reference IBV strains published in GenBank.The results showed that the N gene from the IBV isolate consisted of 1 230 bp,coding 409 amino acids.The M gene from the IBV isolate consisted of 678 bp,coding 225 amino acids.The sequence analysis of N gene showed that it shared 87.2% to 93.3% nucleotide homologies and 90.0% to 94.4% deduced amino acid sequence homologies with IBV strains from GenBank.The M gene sequence analysis showed that it shared 83.6% to 91.0% nucleotide homologies and 82.7% to 92.9% deduced amino acid sequence homologies.The phylogenetic tree analysis showed that it was closely related to BJ and LX4 strains,and were clustered into one group;But with the distant relatives from other strains of IBV.These results suggested that the isolate was a new variant of IBV.